Harbor Capital Advisors Inc. Sells 42,163 Shares of Addus HomeCare Corporation $ADUS

Harbor Capital Advisors Inc. decreased its holdings in Addus HomeCare Corporation (NASDAQ:ADUS) by 62.7% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 25,056 shares of the company’s stock after selling 42,163 shares during the quarter. Harbor Capital Advisors Inc. owned approximately 0.14% of Addus HomeCare worth $2,956,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of ADUS. Leeward Investments LLC MA acquired a new position in Addus HomeCare during the 2nd quarter worth about $9,152,000. TimesSquare Capital Management LLC raised its position in shares of Addus HomeCare by 13.9% during the second quarter. TimesSquare Capital Management LLC now owns 394,047 shares of the company’s stock worth $45,390,000 after acquiring an additional 48,207 shares during the last quarter. Allspring Global Investments Holdings LLC lifted its stake in shares of Addus HomeCare by 162.5% in the second quarter. Allspring Global Investments Holdings LLC now owns 74,317 shares of the company’s stock worth $8,561,000 after acquiring an additional 46,010 shares during the period. Kennedy Capital Management LLC boosted its holdings in Addus HomeCare by 34.3% in the second quarter. Kennedy Capital Management LLC now owns 178,801 shares of the company’s stock valued at $20,596,000 after acquiring an additional 45,670 shares during the last quarter. Finally, Adage Capital Partners GP L.L.C. acquired a new stake in Addus HomeCare during the 2nd quarter valued at approximately $4,838,000. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Addus HomeCare Price Performance

Shares of NASDAQ ADUS opened at $111.17 on Thursday. The firm has a market capitalization of $2.05 billion, a P/E ratio of 23.80, a P/E/G ratio of 1.48 and a beta of 0.94. The firm’s 50-day moving average price is $115.61 and its 200-day moving average price is $113.81. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.14. Addus HomeCare Corporation has a 1-year low of $88.96 and a 1-year high of $136.72.

Addus HomeCare (NASDAQ:ADUS) last issued its earnings results on Monday, November 3rd. The company reported $1.56 EPS for the quarter, beating analysts’ consensus estimates of $1.53 by $0.03. Addus HomeCare had a return on equity of 9.53% and a net margin of 6.36%.The business had revenue of $362.30 million during the quarter, compared to analyst estimates of $354.48 million. During the same period in the previous year, the company posted $1.30 EPS. The firm’s revenue was up 25.0% compared to the same quarter last year. Equities research analysts anticipate that Addus HomeCare Corporation will post 4.59 earnings per share for the current fiscal year.

Insider Activity at Addus HomeCare

In other news, EVP Darby Anderson sold 20,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 19th. The stock was sold at an average price of $109.00, for a total transaction of $2,180,000.00. Following the transaction, the executive vice president directly owned 44,144 shares of the company’s stock, valued at $4,811,696. This represents a 31.18% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders sold a total of 20,316 shares of company stock worth $2,215,998 in the last ninety days. Insiders own 4.50% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on ADUS. Cowen restated a “buy” rating on shares of Addus HomeCare in a research report on Wednesday, November 5th. BMO Capital Markets started coverage on shares of Addus HomeCare in a report on Thursday, November 13th. They issued a “market perform” rating and a $120.00 target price on the stock. Royal Bank Of Canada upped their price target on shares of Addus HomeCare from $134.00 to $139.00 and gave the company an “outperform” rating in a research report on Friday, November 7th. UBS Group began coverage on Addus HomeCare in a research report on Tuesday, September 2nd. They issued a “buy” rating and a $145.00 price objective for the company. Finally, Barclays boosted their price objective on Addus HomeCare from $111.00 to $117.00 and gave the company an “underweight” rating in a research note on Tuesday, November 4th. Eight equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $137.11.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.